Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular and Immunological Signatures in Recurrent Hepatocellular Carcinoma (HCC)

NCT06141564 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT06141564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06141564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular and Immunological Signatures in Recurrent Hepatocellular Carcinoma (HCC)
Lead sponsor
Johns Hopkins University
Phase
Observational
Overall status
Active, not recruiting
Start date
October 16, 2023
Completion date
December 31, 2026
Enrollment
360 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer